id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-353217-gmc3qrci	de Miranda Santos, Isabel Kinney Ferreira	Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus	2020-08-04		.txt	text/plain	551	34	36	Recent large observational studies indicate that hydroxychloroquine (HY) does not affect outcomes of patients hospitalized with COVID-19 (1, 2) and may even be harmful (3) . In view of this situation and of the importance of correct interpretation of antibody profiles for planning preventive measures for COVID-19, we would like to bring the attention of readers to studies that raise concerns about the possible impact of HY upon antibody responses to SARS-CoV-2. To the best of our knowledge, there are no new facts in the scientific and medical literature that indicate that the same mechanism could not operate in HY-treated patients suffering from COVID-19 and negatively impact their SARS-CoV-2-specific antibody responses. As more needs to be learned about the role of antibodies in recovery from and protection against infection with SARS-CoV-2, the impact of HY and other treatment regimens on antibody responses requires systematic evaluation.	./cache/cord-353217-gmc3qrci.txt	./txt/cord-353217-gmc3qrci.txt